Onyx Pharmaceuticals Buys Proteolix, Gaining Blood-Cancer Drug

Onyx Pharmaceuticals Inc. is set to buy Proteolix Inc. for a reported $276 million in order to gain a blood-cancer drug in its experimental stages. The Emeryville, California based company may end up paying $575 million more in future payments for development of the...